Skip to content

COVID19 newsletter issue 2 03.04.2020

COVID19 newsletter issue 1 27.03.2020

Coronavirus COVID-19 

Posted on 04/03/2020 | Updated: 05/04/2020

We have been asked whether people who have been affected by Guillain-Barré syndrome, CIDP or one of the associated inflammatory neuropathies are more at risk from coronavirus COVID-19. The following information is a general guideline only. If you have other health conditions to take into consideration, please seek medical guidance.

GBS / acute variants

The advice for people who have had GBS is the same as for anyone else. A common misconception is that people who have had GBS have a weakened or damaged immune system – this isn’t the case, and you are no more or less likely to contract the coronavirus or to be adversely affected by it.

CIDP / chronic variants

For those of you living with CIDP, or another of the chronic variants, you may have a suppressed immune system, depending on your treatment. Receiving immunoglobulin, either intravenously or subcutaneously, does not suppress your immune system, nor does plasmapheresis (plasma exchange / plex). However, if you take steroids, or other immunosuppressant drugs, then you are considered to be more vulnerable. If you are unsure, ask your GP or neurologist

Instructions for everyone in the UK, effective from 24th March until further notice


  • Only go outside for food, health reasons or essential work
  • Stay 2 metres (6ft) away from other people
  • Wash your hands as soon as you get home

Anyone can spread the virus.

Further information online

Check if you have coronavirus symptoms

Who is considered most at risk and how can we best help them?

Further advice is also available on the NHS website

Advice for people who need to stay at home to ‘self-isolate’

Advice from BBC News online

Public Health England map showing location and numbers of cases throughout the UK

World Health Organisation map showing location and numbers of cases globally

World Health Organisation FAQs